Graves' disease is a common autoimmune disorder that leads to hyperthyroidism, meaning
the thyroid gland produces excessive amounts of thyroid hormones (thyroxine/T4 and
triiodothyronine/T3). This condition has significant implications for various body systems
due to the widespread effects of thyroid hormones on metabolism.
Pathophysiology
Graves' disease is caused by the immune system mistakenly attacking the thyroid gland.
Specifically, B lymphocytes produce an autoantibody called thyroid-stimulating
immunoglobulin (TSI), also known as thyroid-stimulating antibody (TSAb). Unlike most
autoantibodies that inhibit, TSI is stimulatory. It binds to the thyroid-stimulating hormone
(TSH) receptor on the thyroid follicular cells, mimicking the action of TSH from the
pituitary gland. This constant stimulation leads to:
Continuous overproduction and secretion of T4 and T3: This is the primary cause
of hyperthyroidism in Graves' disease.
Enlargement of the thyroid gland (goiter): The constant stimulation causes the
thyroid gland to grow.
The exact trigger for this autoimmune response is not fully understood, but it's believed to
involve a combination of genetic predisposition and environmental factors like stress,
smoking, infections, and iodine exposure.
Extrathyroidal Manifestations: Graves' disease can also affect other parts of the body,
notably the eyes and skin, due to shared antigens or immune responses:
Graves' Orbitopathy (Ophthalmopathy): This affects the muscles and tissues
behind the eyes. It's thought to be caused by TSI and cytokines released by T
lymphocytes activating orbital fibroblasts and preadipocytes. This leads to the
synthesis of hydrophilic glycosaminoglycans (GAGs) and retro-orbital fat growth,
causing inflammation, swelling, and increased pressure behind the eyeballs. This
results in characteristic bulging eyes (exophthalmos), eyelid retraction, double vision,
and eye irritation.
Pretibial Myxedema (Graves' Dermopathy): This is a rare skin condition
characterized by thickened, discolored skin, usually on the shins, with an "orange
peel" appearance. Its pathogenesis is less understood but may involve cytokine-
mediated stimulation of fibroblasts.
Thyroid Acropachy: Even rarer, this involves clubbing of the fingers and toes with
subperiosteal bone formation.
Clinical Features (Symptoms and Signs)
The symptoms of Graves' disease are largely due to hyperthyroidism, which speeds up the
body's metabolism. They can vary in severity and may develop gradually.
General Symptoms of Hyperthyroidism:
Metabolic: Unexplained weight loss despite increased appetite, heat intolerance,
excessive sweating.
Cardiovascular: Rapid or irregular heartbeat (palpitations, tachycardia, atrial
fibrillation), increased pulse pressure.
Neurological: Nervousness, irritability, anxiety, tremor (shaky hands), difficulty
sleeping (insomnia), hyperkinesia.
Gastrointestinal: Frequent bowel movements, diarrhea.
Musculoskeletal: Muscle weakness (especially in hips and shoulders), fatigue.
Reproductive: Irregular menstrual periods or amenorrhea in females, decreased
libido/erectile dysfunction in males.
Hair and Skin: Thin, warm, and moist skin; hair loss; onycholysis (Plummer's nails).
Specific Signs of Graves' Disease (Extrathyroidal Manifestations):
Goiter: Diffusely enlarged, often symmetric, non-tender thyroid gland. A thyroid
bruit may be audible on auscultation.
Graves' Orbitopathy/Ophthalmopathy:
o Exophthalmos (bulging eyes)
o Eyelid retraction (leading to a "staring" appearance)
o Periorbital edema (swelling around the eyes)
o Conjunctival redness and irritation (gritty sensation)
o Light sensitivity (photophobia)
o Pressure or pain in the eyes
o Diplopia (double vision) due to extraocular muscle weakness
o In severe cases, vision loss due to optic nerve compression.
Pretibial Myxedema: Lumpy, discolored thickening of the skin, most commonly on
the shins.
Diagnosis
The diagnosis of Graves' disease typically involves a combination of clinical evaluation,
blood tests, and imaging studies.
1. History and Physical Examination:
o Detailed medical history, including family history of thyroid or other
autoimmune disorders.
o Physical examination to identify characteristic signs such as goiter,
tachycardia, tremor, and especially eye signs of Graves' ophthalmopathy.
2. Blood Tests:
o Thyroid Stimulating Hormone (TSH): This is the most sensitive initial test.
In Graves' disease, TSH levels are typically suppressed (very low or
undetectable).
o Free Thyroxine (FT4) and Free Triiodothyronine (FT3): These levels are
usually elevated, confirming hyperthyroidism.
o TSH Receptor Antibodies (TRAb): Measuring TRAb (specifically TSI) is
crucial for confirming Graves' disease as the cause of hyperthyroidism. High
levels of TRAb have high sensitivity and specificity for Graves' disease.
o Other antibodies: Anti-thyroglobulin antibodies (TgAb) and anti-thyroid
peroxidase antibodies (TPOAb) may also be present, but they are not specific
to Graves' disease and can be seen in other autoimmune thyroid conditions.
3. Imaging Studies:
o Radioactive Iodine Uptake (RAIU) and Scan: The patient swallows a small
amount of radioactive iodine (I-123). The thyroid's uptake of iodine is
measured. In Graves' disease, there is typically a diffusely increased uptake
of radioactive iodine throughout the gland, reflecting its overactivity. This
differentiates Graves' disease from other causes of hyperthyroidism (e.g.,
thyroiditis, which causes low uptake).
o Doppler Ultrasound of the Thyroid: This non-invasive test can show
increased blood flow within the thyroid gland in Graves' disease, indicating
hypervascularity. It's particularly useful when RAIU is contraindicated (e.g.,
pregnancy).
o CT or MRI of the Orbits: Recommended for patients with Graves'
ophthalmopathy to visualize swelling of the extraocular muscles and increased
fat deposits behind the eyeballs.
Treatment
The goal of treatment for Graves' disease is to reduce thyroid hormone production and
alleviate symptoms. The main treatment modalities are:
1. Antithyroid Medications (Thionamides):
o Mechanism: These drugs (e.g., Carbimazole, Methimazole, Propylthiouracil -
PTU) inhibit the synthesis of thyroid hormones by interfering with iodine
organification and coupling reactions within the thyroid gland. PTU also has
the additional effect of blocking the peripheral conversion of T4 to the more
active T3.
o Advantages: Non-invasive, avoids radiation exposure, does not worsen
Graves' ophthalmopathy, can be used in pregnancy (PTU preferred in first
trimester).
o Disadvantages: High relapse rate after discontinuation, requires frequent
monitoring, potential side effects (rash, itching, liver damage, agranulocytosis
- a rare but serious decrease in white blood cells).
2. Radioactive Iodine (RAI) Therapy:
o Mechanism: Oral administration of Iodine-131. The thyroid gland selectively
takes up the radioactive iodine, leading to destruction of thyroid cells over
several weeks to months, thereby reducing hormone production.
o Advantages: Highly effective, definitive treatment for many, avoids surgery.
o Disadvantages: Can exacerbate or cause new Graves' ophthalmopathy
(especially in smokers), often leads to permanent hypothyroidism (requiring
lifelong thyroid hormone replacement), contraindicated in pregnancy and
breastfeeding, patient needs to follow radiation precautions for a period.
3. Thyroidectomy (Surgical Removal of the Thyroid Gland):
o Mechanism: Partial or total removal of the thyroid gland.
o Advantages: Rapid and definitive control of hyperthyroidism, does not
worsen Graves' ophthalmopathy.
o Disadvantages: Invasive procedure with surgical risks (bleeding, infection,
damage to parathyroid glands leading to hypocalcemia, damage to recurrent
laryngeal nerve leading to voice changes), results in permanent
hypothyroidism (requiring lifelong thyroid hormone replacement), scar
formation.
Symptomatic Treatment:
Beta-blockers (e.g., Propranolol): These medications do not reduce thyroid hormone
production but effectively alleviate many hyperthyroid symptoms like rapid heart rate,
tremors, anxiety, and sweating. They are often used as initial therapy to control
symptoms while definitive treatment takes effect.
For Graves' Ophthalmopathy: Lubricating eye drops, cool compresses, elevating
the head of the bed, sunglasses, corticosteroids (for severe inflammation), and in some
cases, orbital decompression surgery or other specialized treatments.
Management Considerations:
Pregnancy: PTU is generally preferred during the first trimester, with a switch to
methimazole in the second and third trimesters. RAI and surgery are contraindicated.
Thyroid Storm: A life-threatening exacerbation of hyperthyroidism requiring
immediate medical attention, often treated with aggressive measures including
antithyroid drugs, beta-blockers, iodine (to block hormone release), and
corticosteroids.
In summary, Graves' disease is a complex autoimmune condition involving hyperthyroidism
and specific extrathyroidal manifestations. A thorough understanding of its pathophysiology,
clinical presentation, diagnostic modalities, and treatment options is crucial for effective
management in medical practice.
